Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05208697 · ClinicalTrials.gov registry record · NA
Tele-Harm Reduction
A NA study of HIV Infections and Hepatitis C, sponsored by University of Miami.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 3
- Study locations
NCT05208697: Active NA study of HIV Infections and Hepatitis C, sponsored by University of Miami.
NCT05208697 is a NA study of HIV Infections and Hepatitis C that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 100 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (78% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05208697, a NA study of HIV Infections and Hepatitis C, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Primary Outcome
HIV viral load \<200 copies/ml time-averaged
Conditions Studied
Interventions
- BEHAVIORAL Tele-Harm Reduction
- OTHER off-site linkage
Study Locations (3)
Florida
- Care Resource The SPOT - Fort Lauderdale
- University of Miami - Miami
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-10-10 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT05208697 still lists
NCT05208697 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Tele-Harm Reduction is the first listed.
NCT05208697 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05208697 about?
NCT05208697 is a clinical study titled "Tele-Harm Reduction". The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
What is the current status of trial NCT05208697?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-10-10. Estimated completion is 2026-04-30.
What conditions does trial NCT05208697 study?
This clinical trial studies the following conditions: HIV Infections, Hepatitis C, IV Drug Usage.
What interventions are being tested in trial NCT05208697?
The interventions under investigation include: Tele-Harm Reduction (BEHAVIORAL), off-site linkage (OTHER).
Who is sponsoring clinical trial NCT05208697?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05208697 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05208697's enrollment target sits among peer trials
100 267th of 542 higher than 267 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI